Acamprosate Calcium is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Marlex Pharmaceuticals Inc. The primary component is Acamprosate Calcium.
| Product ID | 10135-636_931e979e-ca0f-4a7f-a735-ea37286def27 |
| NDC | 10135-636 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Acamprosate Calcium |
| Generic Name | Acamprosate Calcium |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-08-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202229 |
| Labeler Name | Marlex Pharmaceuticals Inc |
| Substance Name | ACAMPROSATE CALCIUM |
| Active Ingredient Strength | 333 mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2016-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202229 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-08-01 |
| Ingredient | Strength |
|---|---|
| ACAMPROSATE CALCIUM | 333 mg/1 |
| SPL SET ID: | a815699f-90ee-41ba-838c-11951aeda90f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-5352 | Acamprosate Calcium | Acamprosate Calcium |
| 0378-6333 | Acamprosate Calcium | acamprosate calcium enteric-coated |
| 0904-7213 | Acamprosate Calcium | Acamprosate Calcium |
| 10135-636 | Acamprosate Calcium | Acamprosate Calcium |
| 42291-104 | Acamprosate Calcium | Acamprosate Calcium |
| 51079-241 | Acamprosate Calcium | acamprosate calcium enteric-coated |
| 60687-121 | Acamprosate Calcium | Acamprosate Calcium |
| 68382-569 | acamprosate calcium | acamprosate calcium |
| 68462-435 | Acamprosate Calcium | Acamprosate Calcium |
| 70771-1057 | acamprosate calcium | acamprosate calcium |
| 68151-4760 | Campral | acamprosate calcium |